Neuroendocrine Tumor Research Funding
The Neuroendocrine Tumor Research Foundation (NETRF) was founded by a patient, Nancy Lindholm, in 2005, with the mission to discover cures and more effective treatments for neuroendocrine tumors (NETs). Since 2005, we have funded over 60 research projects, totaling more than $26 million in NET research.
As the leading funder of neuroendocrine tumor research, our goal is to transform the NET research landscape by supporting cutting-edge basic, translational, and clinical research, recruiting new investigators to NETs, and fostering a collaborative, scientific community that works together to understand the origin and development of neuroendocrine tumors, in an effort to create more effective therapies.
We are grateful to the generous gifts from our donors that make our work possible.
The latest in NET News
A NETRF-funded clinical trial looks at a cancer vaccine called SurVaxM in neuroendocrine cancer to help slow or stop the spread of neuroendocrine tumors.
Latest in NET Cancer Research Neuroendocrine Tumor Research Foundation (NETRF) held its 11th Annual Research
NETRF Announces 2019 Neuroendocrine Cancer Research Funding Opportunities New award to fund early career investigators